The experimental results were consistent with the expected results: PHKG2 overexpression significantly increased the ferritinophagy after radiotherapy and increased iron levels and mitochondrial dysfunction in the tissues after radiotherapy, which promoted the ferroptosis after radiotherapy and augmented the sensitivity of NSCLC to radiotherapy. The gene discussed is PHKG2; the disease is non-small cell lung carcinoma.